MAJIC trial results: ruxolitinib compared to best available therapy for essential thrombocythemia
Myeloma 2016: Panel discussion on the environment biology of myeloma
Dirk Hose et al.
Allogeneic transplant in multiple myeloma: who should receive it and the future of transplant
Heinz Ludwig et al.
Trial results and drug combinations for bortezomib in multiple myeloma
Germline predispositions in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
Jane E. Churpek